Bradley J. Bolzon Ph.D., Director, 10% Owner at Black Diamond Therapeutics, Inc. (BDTX), sold 58,558 shares at $33.13 ($682K) on 2020-11-30, disclosed to the SEC on 2020-12-01.
Open-market sale of $682k BDTX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 6,797 | $0 | 0.0% |
| 2 | $0.00 | 31,175 | $0 | 0.0% |
| 3 | $33.13 | 10,193 | $338K | 49.5% |
| 4 | $33.13 | 10,193 | $338K | 49.5% |
| 5 | $34.16 | 200 | $7K | 1.0% |
| Total | $11.65 avg | 58,558 |
| $682K |
| 100% |
| Filing → |
| CRSP | SELL | 2021-06-30 | $14.1M | — | Filing → |
| CRSP | SELL | 2021-06-30 | $9.2M | — | Filing → |
| CRSP | SELL | 2021-06-15 | $2.3M | — | Filing → |